Please select the outcome measures that correspond to the clinical trial below.
Title: Reducing Distress and Improving Self-Care in Diabetes
Brief Summary: To date, there have been few practical, evidenced based interventions that are directed at patients with Type II Diabetes who are experiencing depressed and/or emotional distress in primary care settings. This study will (1) combine two existing, evidenced-based, interventions (a computer automated, diabetes specific self-management program (CASM) vs. a self-care program plus a live problem solving distress-reduction program (CAPS) vs. a lifestyle and activities education program (LEAP-AHEAD)) into a practical, 3-arm clinical trial with a highly distressed multi-ethnic patient sample, and (2) evaluate the intervention using the RE-AIM framework, sharing the results through a comprehensive dissemination package.

Hypothesis 1: The combined CASM and CAPS arms will be superior to the LEAP-AHEAD group on the primary outcomes at follow-up.

Hypothesis 2: The CAPS arm will be superior to the CASM arm on primary outcomes at follow-up.


Options:
A: Score of Seattle Angina Questionnaire（SAQ ） (at the 0-week); Score of Seattle Angina Questionnaire（SAQ ） (at the 4-week); Score of Seattle Angina Questionnaire（SAQ ） (at the 8-week); Score of Seattle Angina Questionnaire（SAQ ） (at the 12-week); Frequency of angina pectoris related symptoms every week (at the 0-week); Frequency of angina pectoris related symptoms every week (at the 1-week); Frequency of angina pectoris related symptoms every week (at the 2-week); Frequency of angina pectoris related symptoms every week (at the 3-week); Frequency of angina pectoris related symptoms every week (at the 4-week); Frequency of angina pectoris related symptoms every week (at the 5-week); Frequency of angina pectoris related symptoms every week (at the 6-week); Frequency of angina pectoris related symptoms every week (at the 7-week); Frequency of angina pectoris related symptoms every week (at the 8-week); Frequency of angina pectoris related symptoms every week (at the 9-week); Frequency of angina pectoris related symptoms every week (at the 10-week); Frequency of angina pectoris related symptoms every week (at the 11-week); Frequency of angina pectoris related symptoms every week (at the 12-week)
B: Weight loss (6-12 months)
C: Change in depressive symptoms as a result of intervention effects (Baseline, 3, 6 and 12 months); Change in intervention effects on depressive symptoms moderated by perceived stigma (Baseline, 3, 6, and 12 months); Change in intervention effects on depressive symptoms moderated by sex (Baseline, 3, 6, and 12 months)
D: Diet. Starting the Conversation is a 9 items measure of eating patterns (including 2 items from the NCI Fruit and Vegetable Screener). NCI Percent Energy from Fat Screen (PFAT) contains 17 items concerning frequency of intake for 15 food groups. (Baseline, 16 weeks, and 12 months); Physical Activity. The CHAMPS (28 items) will be used to measure physical activity. (Baseline, 16 weeks, and 12 months); Medication Adherence. Medication taking will be assessed by the Hill-Bone Medication Adherence scale. Questions will also cover smoking and alcohol use. (Baseline, 16 weeks, and 12 months); Distress. Patient distress will be assessed across several measures including: the 20-item CES-D, the 17-item DDS, the PHQ8, and screening items from the SCID to rule out psychosis. (Baseline, 16 weeks, and 12 months)

Answer: D